Diagnos Inc.

Diagnos Inc.

September 06, 2011 12:48 ET

DIAGNOS Retains the Services of Louis Morin for its Investor Relations Activities

BROSSARD, QUEBEC, CANADA--(Marketwire - Sept. 6, 2011) - DIAGNOS inc. ("DIAGNOS" or the "Corporation")(TSX VENTURE:ADK), a leader in the use of artificial intelligence ("AI") and advanced knowledge extraction techniques, announced today that it has retained the services of Mr. Louis Morin to handle its investor relations activities.

Based in Montréal, Mr. Morin is a specialist in Investor Relations. Due to his proactive communication program, he increases the visibility of small and micro cap companies to financial institutions in Canada.

"We are pleased to announce that we have selected Mr. Morin to strengthen DIAGNOS' profile in the financial community. We believe that he will enhance the Company's visibility, thanks to its investor relations strategies and methodology," noted Mr. André Larente, President of DIAGNOS.

The service contract is for twelve (12) months for a monthly retainer of $6,000. Furthermore, on August 30, 2011, the Board of Directors has approved a grant of 250,000 stock options, subject to regulatory approval, to Mr. Morin, under the terms of the share stock option plan of the Corporation approved by the Shareholders in September 2008. The exercise price has been established at $0.29 per share for the first tranche of 33% options vested one year after the grant date, $0.35 per share for second tranche of 33% options vested after two years of the grant date and $0.40 per share for the last tranche vested three years after the grant date. The expiry date where these options can be exercised has been fixed to September 5, 2016.


Founded in 1998, DIAGNOS is a publicly traded Canadian corporation (TSX VENTURE:ADK), with a mission to commercialize technologies combining contextual imaging and traditional data mining thereby improving decision making processes. DIAGNOS offers products, services, and solutions to clients in a variety of fields including healthcare, natural resources, and entertainment.

For further information, please visit our website at www.diagnos.com or the SEDAR website at www.sedar.com

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. All monies quoted in this press release shall be stated and paid in lawful money of Canada.

Contact Information